Cite
MLA Citation
Victor Moreno et al.. “794 Safety and efficacy results from a phase 1/1b study of intratumoral MK-4621, a retinoic acid-inducible gene I (RIG-I) agonist, plus intravenous pembrolizumab in patients with advanced solid tumors.” Journal for immunotherapy of cancer, vol. 8, n.d., pp. A474–A475. http://access.bl.uk/ark:/81055/vdc_100144728682.0x000006